{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:26:11Z","timestamp":1785252371692,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.xfre.2022.06.005","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T13:26:29Z","timestamp":1656595589000},"page":"223-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of increasing antim\u00fcllerian hormone level on in\u00a0vitro fertilization fresh transfer and live birth rate"],"prefix":"10.1016","volume":"3","author":[{"given":"Kelly S.","family":"Acharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5923-4037","authenticated-orcid":false,"given":"Tracy","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2022.06.005_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","article-title":"Anti-mullerian hormone in PCOS: a review informing international guidelines","volume":"30","author":"Teede","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib2","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/humrep\/deq019","article-title":"Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles","volume":"25","author":"Andersen","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2022.06.005_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.fertnstert.2005.01.115","article-title":"Per-follicle measurements indicate that anti-mullerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status","volume":"84","author":"Fanchin","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-mullerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells","volume":"96","author":"Pellatt","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2022.06.005_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fertnstert.2007.02.014","article-title":"Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance","volume":"88","author":"Seifer","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/AOG.0b013e3182116bc8","article-title":"Antimullerian hormone as a predictor of natural fecundability in women aged 30-42 years","volume":"117","author":"Steiner","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2022.06.005_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0033-1356479","article-title":"Biomarkers of ovarian reserve as predictors of reproductive potential","volume":"31","author":"Steiner","year":"2013","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.xfre.2022.06.005_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association between biomarkers of ovarian reserve and infertility among older women of reproductive age","volume":"318","author":"Steiner","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.xfre.2022.06.005_bib10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2011-3032","article-title":"Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women","volume":"97","author":"Freeman","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib11","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1210\/jc.2012-4228","article-title":"The relationship between anti-Mullerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies","volume":"98","author":"D\u00f3lleman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib12","article-title":"Validation of the picoAMH assay on the Dynex DS2 platform","volume":"17","author":"Garnett","year":"2019","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.xfre.2022.06.005_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women","volume":"77","author":"Cook","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(97)81417-3","article-title":"Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis","volume":"67","author":"Fallat","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib16","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.fertnstert.2005.06.026","article-title":"M\u00fcllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B","volume":"84","author":"Chu","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2022.06.005_bib22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in\u00a0vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2022.06.005_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xfre.2022.06.005_bib26","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women","volume":"96","author":"Broer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib27","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2022.06.005_bib28","series-title":"American Society for Reproductive Medicine, and Society for Assisted Reproductive Technology. 2012 assisted reproductive technology and success rates: national summary and fertility clinic reports","year":"2014"},{"key":"10.1016\/j.xfre.2022.06.005_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfre.2022.06.005_bib30","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.fertnstert.2009.12.002","article-title":"Serum antimullerian hormone concentrations on day 3 of the in\u00a0vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction","volume":"94","author":"Kaya","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2017.10.021","article-title":"Antimullerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013","volume":"109","author":"Tal","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfre.2022.06.005_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-020-00581-4","article-title":"High serum antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology","volume":"18","author":"Tal","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xfre.2022.06.005_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","article-title":"Correlation of serum anti-mullerian hormone concentrations on day 3 of the in\u00a0vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients","volume":"29","author":"Xi","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.xfre.2022.06.005_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2008-1042958","article-title":"Oocyte quality in adult polycystic ovary syndrome","volume":"26","author":"Patel","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.xfre.2022.06.005_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfre.2022.06.005_bib38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/1933719115618283","article-title":"Hyperandrogenism decreases GRP78 protein level and glucose uptake in human endometrial stromal cells","volume":"23","author":"Rosas","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.xfre.2022.06.005_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0035-1552582","article-title":"The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome","volume":"33","author":"Tal","year":"2015","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.xfre.2022.06.005_bib40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.fertnstert.2018.05.024","article-title":"Freezing of all embryos in in\u00a0vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry","volume":"110","author":"Acharya","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2022.06.005_bib41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus frozen embryos for infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xfre.2022.06.005_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2022.06.005_bib43","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2022.06.005_bib44","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.fertnstert.2021.05.094","article-title":"Antimullerian hormone to determine polycystic ovarian morphology","volume":"116","author":"de Loos","year":"2021","journal-title":"Fertil Steril"}],"container-title":["F&S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266633412200068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266633412200068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:37:09Z","timestamp":1762637829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266633412200068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S266633412200068X"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2022.06.005","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of increasing antim\u00fcllerian hormone level on in\u00a0vitro fertilization fresh transfer and live birth rate","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2022.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}